In that study, decreased TMEM52B expression was correlated with poor survival and von Hippel-Lindau mutations in renal cell carcinoma patients [10], suggesting that decreased TMEM52B expression may promote renal carcinogenesis. Here, TMEM52B is linked to hereditary clear cell renal cell carcinoma.